Millennium Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-30,000
Closed -$664K – 6762
2021
Q3
$664K Buy
+30,000
New +$476K ﹤0.01% 5075

Other funds holding AUPH

Millennium Management's AUPH Position: Q3 2026 in Review

Millennium Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 93% in Q3 2026, selling an estimated $3.63M and leaving 16,895 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #5406.

Millennium Management first reported a position in AUPH in Q1 2015 and has held it in 38 quarters since. The position peaked at $39.4M in Q4 2019. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Millennium Management held 16,895 shares of Aurinia Pharmaceuticals worth $274K as of Q3 2026.
  • Millennium Management sold 227,407 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $3.63M.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5406 holding.
  • Millennium Management first reported a position in Aurinia Pharmaceuticals in Q1 2015 and has held it in 38 quarters since.
  • Millennium Management's Aurinia Pharmaceuticals position peaked at $39.4M in Q4 2019.
  • 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.